Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
SRI International, Menlo Park, CA, USA.
L
L
Toll
I P
IP
Berzetei-Gurske
W E
WE
Polgar
S R
SR
Brandt
I D
ID
Adapa
L
L
Rodriguez
R W
RW
Schwartz
D
D
Haggart
A
A
O'Brien
A
A
White
J M
JM
Kennedy
K
K
Craymer
L
L
Farrington
J S
JS
Auh
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000378:metabolism; D003042:Cocaine; D000242:Cyclic AMP / Q000096:biosynthesis; D004558:Electric Stimulation; D006168:Guinea Pigs; D006801:Humans; D007082:Ileum / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009293:Opioid-Related Disorders / Q000188:drug therapy*; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D011957:Receptors, Opioid / Q000187:drug effects* / Q000378:metabolism; D011985:Receptors, Serotonin / Q000187:drug effects / Q000378:metabolism; D019966:Substance-Related Disorders / Q000188:drug therapy*
D011954:Receptors, Dopamine; D011957:Receptors, Opioid; D011985:Receptors, Serotonin; D000242:Cyclic AMP; D003042:Cocaine